Abstract
Superoxide, hydrogen peroxide, hydroxyl radicals and peroxynitrite are collectively termed reactive oxygen and nitrogen species (RONS). They have been ascribed an important role in oxidative stress contributing to the progression of inflammatory diseases. RONS generating systems include the inflammatory response, enzymatic pathways and as side products of catabolism. Protective enzymes exist for the regulation of RONS such as superoxide dismutase, catalase and glutathione peroxidase. Furthermore, vitamins play a secondary role in deactivating RONS. The redox active metal ions such as ferrous and cuprous ions are released from the storage proteins ferritin and caeruloplasmin by RONS. Redox active metal ions further activate/generate RONS and thus perpetuate their damaging effects. Here we report recent therapies that focus on intervening in the roles of metal ions in oxidative stress. These include: i) chelators which complex labile metal ions to form antioxidant enzyme mimetics, ii) site-specific RONS scavengers, where dual functionality colocalizes the scavenger and chelation centre to direct scavenging, and iii) redox silencing, metal complexation with concomitant stabilization of the metal ion in the oxidized form to prevent further activation of RONS. The rationale for this new therapeutic approach and recent advances will be presented in this review.
Keywords: metal ions, oxidative stress, chelation, antioxidants, inflammation, neurodegeneration
Current Drug Delivery
Title: Therapeutic Chelators for the Twenty First Century: New Treatments for Iron and Copper Mediated Inflammatory and Neurological Disorders
Volume: 2 Issue: 3
Author(s): Anna E.O. Fisher and Declan P. Naughton
Affiliation:
Keywords: metal ions, oxidative stress, chelation, antioxidants, inflammation, neurodegeneration
Abstract: Superoxide, hydrogen peroxide, hydroxyl radicals and peroxynitrite are collectively termed reactive oxygen and nitrogen species (RONS). They have been ascribed an important role in oxidative stress contributing to the progression of inflammatory diseases. RONS generating systems include the inflammatory response, enzymatic pathways and as side products of catabolism. Protective enzymes exist for the regulation of RONS such as superoxide dismutase, catalase and glutathione peroxidase. Furthermore, vitamins play a secondary role in deactivating RONS. The redox active metal ions such as ferrous and cuprous ions are released from the storage proteins ferritin and caeruloplasmin by RONS. Redox active metal ions further activate/generate RONS and thus perpetuate their damaging effects. Here we report recent therapies that focus on intervening in the roles of metal ions in oxidative stress. These include: i) chelators which complex labile metal ions to form antioxidant enzyme mimetics, ii) site-specific RONS scavengers, where dual functionality colocalizes the scavenger and chelation centre to direct scavenging, and iii) redox silencing, metal complexation with concomitant stabilization of the metal ion in the oxidized form to prevent further activation of RONS. The rationale for this new therapeutic approach and recent advances will be presented in this review.
Export Options
About this article
Cite this article as:
Fisher E.O. Anna and Naughton P. Declan, Therapeutic Chelators for the Twenty First Century: New Treatments for Iron and Copper Mediated Inflammatory and Neurological Disorders, Current Drug Delivery 2005; 2 (3) . https://dx.doi.org/10.2174/1567201054367940
DOI https://dx.doi.org/10.2174/1567201054367940 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leptin in Non-Autoimmune Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?
CNS & Neurological Disorders - Drug Targets TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Current Drug Targets Biology of Mesenchymal Stem Cells
Current Rheumatology Reviews Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Current Pharmaceutical Design The Biology of Persistent Infection: Inflammation and Demyelination Following Murine Coronavirus Infection of the Central Nervous System
Current Immunology Reviews (Discontinued) Endogeneous Remyelination: Findings in Human Studies
CNS & Neurological Disorders - Drug Targets Ex Vivo Gene Therapy and Vision
Current Gene Therapy Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders
Current Clinical Pharmacology 14-3-3 Protein in CSF Reflects SIV-Mediated Pre-Synaptic Damage
Current HIV Research Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
Current Neuropharmacology Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Current Neuropharmacology Involvement of IL-1R/TLR Signalling in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Current Molecular Medicine Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Current Pharmaceutical Design Interleukin-10
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy